SEARCH

SEARCH BY CITATION

References

  • 1
    ParkinDM, WhelanSL, FerlayJ, TeppoL, ThomasDB, eds. Cancer incidence in five continents, vol. VIII. Lyon: IARC Press, 2002. IARC Scientific Publications No. 155.
  • 2
    Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirusvirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; 88: 6373.
  • 3
    Castellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, Meijer CJ, Bosch FX. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 2006; 98: 30315.
  • 4
    Berrington de González A, Sweetland S, Green J. Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis. Br J Cancer 2004; 90: 178791.
  • 5
    International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical cancer and 33,542 women without cervical cancer from 25 epidemiological studies. Int J Cancer 2006; 119: 110824.
  • 6
    International Collaboration of Epidemiological Studies of Cervical Cancer. Carcinoma of the cervix and tobacco smoking: collaborative re-analysis of individual data on 15,756 women with carcinoma of the cervix and 29,043 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006; 118: 148195.
  • 7
    Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 51827.
  • 8
    WHO. In: TavassoliFA, StrattonMR, eds. WHO classification of tumours: pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press, 2002. Chapter 5: Tumours of the Uterine Cervix, pp 25989.
  • 9
    Plummer M. Improved estimates of floating absolute risk. Stat Med 2004; 23: 93104.
  • 10
    Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 41927.
  • 11
    Brinton LA, Huggins GR, Lehman HF, Mallin K, Savitz DA, Trapido E, Rosenthal J, Hoover R. Long-term use of oral contraceptives and risk of invasive cervical cancer. Int J Cancer 1986; 38: 33944.
  • 12
    Green J, Berrington de Gonzalez A, Sweetland S, Beral V, Chilvers C, Crossley B, Deacon J, Hermon C, Jha P, Mant D, Peto J, Pike M, Vessey MP. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20–44 years: the UK National case-control study of cervical cancer. Br J Cancer 2003; 89: 207886.
  • 13
    Daling JR, Madeleine MM, McKnight B, Carter JJ, Wipf GC, Ashley R, Schwartz SM, Beckmann AM, Hagensee ME, Mandelson MT, Galloway DA. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev 1996; 5: 5418.
  • 14
    Madeleine MM, Daling JR, Schwartz SM, Shera K, McKnight B, Carter JJ, Wipf GC, Critchlow CW, McDougall JK, Porter P, Galloway DA. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiol Biomarkers Prev 2001; 10: 1717.
  • 15
    Lacey JVJ, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Greenberg MD, Greene SM, Hadjmichael OC, McGowan L, Mortel R, Schwartz PE, Silverberg SG et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 1999; 8: 107985.
  • 16
    Silins I, Wang X, Tadesse A, Jansen KU, Schiller JT, Avall-Lundqvist E, Frankendal B, Dillner J. A population-based study of cervical carcinoma and HPV infection in Latvia. Gynecol Oncol 2004; 93: 484492.
  • 17
    WHO. Invasive squamous-cell cervical carcinoma and combined oral contraceptives: results from a multinational study. WHO collaborative study of neoplasia and steroid contraceptives. Int J Cancer 1993; 55: 22836.
  • 18
    Herrero R, Brinton L, Reeves WC, Brenes MM, Tenorio F, de Britton R, Gaitan E, Montalvan P, Garcia M, Rawls WE. Risk factors for invasive carcinoma of the uterine cervix in Latin America. Bull Pan Am Health Organ 1990; 24: 26383.
  • 19
    Parazzini F, La Vecchia C, Negri E, Maggi R. Oral contraceptive use and invasive cervical cancer. Int J Epidemiol 1990; 19: 25963.
  • 20
    Rolon PA, Smith JS, Munoz N, Klug SJ, Herrero R, Bosch X, Llamosas F, Meijer CJ, Walboomers JM. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 2000; 85: 48691.
  • 21
    Eluf-Neto J, Booth M, Munoz N, Bosch FX, Meijer CJ, Walboomers JM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994; 69: 11419.
  • 22
    Chichareon S, Herrero R, Munoz N, Bosch FX, Jacobs MV, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer CJ, Walboomers JM. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998; 90: 507.
  • 23
    Ngelangel C, Munoz N, Bosch FX, Limson GM, Festin MR, Deacon J, Jacobs MV, Santamaria M, Meijer CJ, Walboomers JM. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 1998; 90: 439.
  • 24
    Chaouki N, Bosch FX, Munoz N, Meijer CJ, El Gueddari B, El Ghazi A, Deacon J, Castellsague X, Walboomers JM. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998; 75: 54654.
  • 25
    Santos C, Munoz N, Klug SJ, Almonte M, Guerrero E, Alvarez M, Velarde C, Galdos O, Walboomers JM, Meijer C, Caceres E. HPV types and cofactors causing cervical cancer in Peru. Br J Cancer 2001; 85: 96671.
  • 26
    Hammouda D, Munoz N, Herrero R, Arlsan A, Bouhadef A, Oublil M, Djedeat B, Fontaniere B, Snijders P, Meijer C, Franceschi S. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer 2004; 113: 4839.
  • 27
    Rajkumar T, Franceschi S, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders P, Munoz N, Herrero R. Role of paan chewing and dietary habits in cervical carcinoma in Chennai, India. Br J Cancer 2003; 88: 138893.
  • 28
    Thomas DB, Qin Q, Kuypers J, Kiviat N, Ashley R, Koetsawang A, Ray RM, Koetsawang S. Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas. Am J Epidemiol 2001; 153: 7329.
  • 29
    Sitas F, Pacella-Norman R, Carrara H, Patel M, Ruff P, Sur R, Jentsch U, Hale M, Rowji P, Saffer D, Connor M, Bull D, Newton R, Beral V. The spectrum of HIV-1 related cancers in South Africa. Int J Cancer 2000; 88: 48992.
  • 30
    Zielinski GD, Snijders PJ, Rozendaal L, Daalmeijer NF, Risse EK, Voorhorst FJ, Jiwa NM, van der Linden HC, de Schipper FA, Runsink AP, Meijer CJ. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix. J Pathol 2003; 201: 53543.
  • 31
    Sasieni P, Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet 2001; 357: 14903.